Ascendis Pharma A/S financial data

Symbol
ASND on Nasdaq
Location
Tuborg Boulevard 12, Hellerup, Denmark
State of incorporation
Denmark
Fiscal year end
December 31
Latest financial report
20-F - Q4 2024 - Feb 12, 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 60.7M shares +5.17%

Income Statement

Label TTM Value / Value Unit Change %
Research And Development Expense 73.5M EUR -34%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets 1.18B EUR +42.9%
Liabilities 1.29B EUR +32.3%